1. Home
  2. REFR vs VNRX Comparison

REFR vs VNRX Comparison

Compare REFR & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REFR
  • VNRX
  • Stock Information
  • Founded
  • REFR 1965
  • VNRX N/A
  • Country
  • REFR United States
  • VNRX United States
  • Employees
  • REFR N/A
  • VNRX N/A
  • Industry
  • REFR Multi-Sector Companies
  • VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • REFR Miscellaneous
  • VNRX Health Care
  • Exchange
  • REFR Nasdaq
  • VNRX Nasdaq
  • Market Cap
  • REFR 67.4M
  • VNRX 67.2M
  • IPO Year
  • REFR N/A
  • VNRX N/A
  • Fundamental
  • Price
  • REFR $1.97
  • VNRX $0.68
  • Analyst Decision
  • REFR
  • VNRX Strong Buy
  • Analyst Count
  • REFR 0
  • VNRX 4
  • Target Price
  • REFR N/A
  • VNRX $4.17
  • AVG Volume (30 Days)
  • REFR 27.0K
  • VNRX 135.1K
  • Earning Date
  • REFR 11-07-2024
  • VNRX 11-14-2024
  • Dividend Yield
  • REFR N/A
  • VNRX N/A
  • EPS Growth
  • REFR N/A
  • VNRX N/A
  • EPS
  • REFR N/A
  • VNRX N/A
  • Revenue
  • REFR $1,469,616.00
  • VNRX $1,285,827.00
  • Revenue This Year
  • REFR N/A
  • VNRX $180.66
  • Revenue Next Year
  • REFR N/A
  • VNRX $558.69
  • P/E Ratio
  • REFR N/A
  • VNRX N/A
  • Revenue Growth
  • REFR 102.07
  • VNRX 88.32
  • 52 Week Low
  • REFR $0.90
  • VNRX $0.43
  • 52 Week High
  • REFR $2.41
  • VNRX $1.23
  • Technical
  • Relative Strength Index (RSI)
  • REFR 40.92
  • VNRX 50.19
  • Support Level
  • REFR $1.92
  • VNRX $0.55
  • Resistance Level
  • REFR $2.31
  • VNRX $0.80
  • Average True Range (ATR)
  • REFR 0.11
  • VNRX 0.07
  • MACD
  • REFR -0.02
  • VNRX 0.01
  • Stochastic Oscillator
  • REFR 12.82
  • VNRX 52.00

About REFR Research Frontiers Incorporated

Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light. The company develops and licenses its patented suspended particle device light-control technology to other companies that manufacture and market the SPD-Smart chemical emulsion, the light-control film made from the chemical emulsion, the light-control panels made by laminating the film, electronics to power end-products incorporating the film, or lamination services for, and the end-products. Its revenue source comes from the licensing of technology.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: